Results overview: Found 3 records in 0.01 seconds.
Articles, 3 records found
Articles 3 records found  
1.
8 p, 1.0 MB Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma / Moreau, Philippe (University Hospital Hôtel-Dieu) ; Van De Donk, Niels WCJ (Department of Hematology. Amsterdam University Medical Center) ; Nahi, Hareth (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nooka, Ajay K (Winship Cancer Institute. Emory University) ; Martin, Thomas (University of California San Francisco) ; Rosinol, Laura (Hospital Clínic i Provincial de Barcelona) ; Karlin, Lionel (Centre Hospitalier Lyon Sud) ; Benboubker, Lotfi (Hôpital Bretonneau) ; Mateos, Maria-Victoria (University Hospital de Salamanca) ; Popat, Rakesh (University College London Hospitals) ; Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ; Sidana, Surbhi (Stanford University of Medicine) ; Delforge, Michele (University of Leuven) ; Pei, Lixia (Janssen Research & Development) ; Trancucci, Danielle (Janssen Research & Development) ; Olyslager, Yunsi (Janssen Research & Development) ; Uhlar, Clarissa (Janssen Research & Development) ; Stephenson, Tara (Janssen Research & Development) ; Rampelbergh, Rian Van (Janssen Research & Development) ; Banerjee, Arnob (Janssen Research & Development) ; Kobos, Rachel (Janssen Research & Development) ; Usmani, Saad Z (Levine Cancer Institute-Atrium Health)
What is this summary about? This is a summary of a phase 1-2 clinical trial called MajesTEC-1. This trial tested the cancer drug teclistamab in people with relapsed or refractory multiple myeloma, a cancer that forms in a certain type of white blood cells known as plasma cells. [...]
2023 - 10.2217/fon-2023-0171
Future oncology (London, England), Vol. 19 Núm. 12 (january 2023) , p. 811-818  
2.
9 p, 603.3 KB Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study / Martin, Thomas G. (University of California San Francisco, USA) ; Moreau, Philippe (University Hospital Hôtel-Dieu, Nantes, France) ; Usmani, Saad Z. (Levine Cancer Institute/Atrium Health, Charlotte, NC) ; Garfall, Alfred (University of Pennsylvania, Philadelphia, PA) ; Mateos, M. V (Hospital Universitario de Salamanca) ; San-Miguel, Jesús F. (Clínica Universidad de Navarra) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Nooka, Ajay K. (Emory University, Atlanta, GA) ; Rosiñol, Laura (Hospital Clínic i Provincial de Barcelona) ; Chari, Ajay (Mount Sinai School of Medicine, New York, USA) ; Karlin, Lionel (Centre Hospitalier Lyon Sud, Pierre-Bénite, France) ; Krishnan, Amrita (City of Hope National Medical Center (Duarte, Estats Units d'Amèrica)) ; Bahlis, Nizar (University of Calgary, Canada) ; Popat, Rakesh (University College London) ; Besemer, Britta (University of Tuebingen, Tuebingen, Germany) ; Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ; Delforge, Michel (Universitaire Ziekenhuizen Leuven, Belgium) ; Trancucci, Danielle (Janssen Research & Development, Raritan, NJ) ; Pei, Lixia (Janssen Research & Development, Raritan, NJ) ; Kobos, Rachel (Janssen Research & Development, Raritan, NJ) ; Fastenau, John (Janssen Research & Development, Raritan, NJ) ; Gries, Katharine S. (Janssen Research & Development, Raritan, NJ) ; van de Donk, Niels W.C.J. (Amsterdam University Medical Center, Vrije Universiteit Amsterdam, The Netherlands)
Introduction: Patients with relapsed or refractory multiple myeloma (RRMM) report significantly lower HRQoL compared with patients with newly diagnosed MM and experience further deterioration in HRQoL with each relapse and subsequent treatment. [...]
2023 - 10.1016/j.clml.2023.11.001
Clinical Lymphoma, Myeloma & Leukemia, 2023  
3.
12 p, 780.3 KB Observational cohort study of rilpivirine (RPV) utilization in Europe / Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ; Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ; De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ; Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ; Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ; Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ; Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ; Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ; Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ; Kusejko, Katharina (University Hospital Zürich (Switzerland)) ; Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ; Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ; Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ; Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ; Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ; Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ; Van Eygen, Veerle (Janssen Research & Development) ; Pai, Helen (Janssen Research & Development) ; Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ; Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ; Harxhi, Arjan (Medical University of Tirana (Albania)) ; Losso, Marcelo Horacio (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ; Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ; Schmied, Brigitte (Institute of Science and Technology Austria (ISTA)) ; Karpov, Igor Alexandrovich (Belarusian State Medical University (Minsk)) ; Vassilenko, Anna (Belarusian State Medical University (Minsk)) ; Paduto, Dmitriy (Regional AIDS Centre (Svetlogorsk, Bèlgica)) ; Mitsura, Victor (Gomel State Medical University) ; Clumeck, Nathan (University Hospital Brussels) ; De Wit, Stéphane A. (Université Libre de Bruxelles) ; Delforge, Marc D. (Université Libre de Bruxelles) ; Hadziosmanovic, Vesnadarjan (Clinical Center University of Sarajevo) ; Begovac, Josip (University of Zagreb) ; Machala, Ladislav (Charles University in Prague) ; Jilich, David (Charles University in Prague) ; Gerstoft, Jan (IT University of Copenhagen) ; Torp-Pedersen, Christian (Aalborg Universitet) ; Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ; Kronborg, Gitte (University of Copenhagen) ; Benfield, Thomas (Copenhagen University Hospital Hvidovre) ; Johansen, IS (Odense University Hospital (Dinamarca)) ; Ostergaard, Leif (Aarhus University) ; Wiese, Lothar (Roskilde University) ; Friis-Moller, Nina (Zealand University Hospital) ; Nielsen, Lars Norregård (Hillerod Hospital (Hillerod, Dinamarca)) ; Zilmer, Kai (Kaunas University of Technology) ; Smidt, Jelena (Kohtla - Jarve Jarve Gümnaasium) ; Aho, Inka (Helsinki University Central Hospital) ; Viard, Jean-Paul (Université Paris Cité) ; Girard, Pierre-Marie (University of Paris-Est) ; Pradier, Christian (Centre Hospitalier Universitaire de Nice) ; Fontas, Eric (Centre Hospitalier Universitaire de Nice) ; Duvivier, Claudine (Hôpital Universitaire Necker) ; Rockstroh, Jurgen (Universitätsklinikum Bonn) ; Degen, Olaf (University Medical Center Hamburg) ; Hoffmann, C. (IPM Study Center) ; Stellbrink, H.J. (IPM Study Center) ; Stefan, C. (JW Goethe University Hospital (Frankfurt)) ; Bogner, Johannes (University Hospital München) ; Fätkenheuer, Gerd (University of Cologne) ; Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ; Sambatakou, Helen (Hippokration General Hospital (Athens)) ; Paissios, N. (Athens General Hospital "G Gennimatas") ; Uzdaviniene, V. (Vilnius University Hospital Santariskiu Clinics) ; Staub, T. (Centre Hospitalier de Luxembourg) ; Dragas, S. ; Reiss, P. (University of Amsterdam) ; Trajanovska, J. (University Clinic for Infectious Diseases & Febrile Conditions (Skopje)) ; Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ; Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ; Bruun, Johan (University Hospital of North Norway) ; Knysz, B. (WWF Poland) ; Szetela, Bartosz (Nicolaus Copernicus University) ; Inglot, Malgorzata (Wroclaw Medical University) ; Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ; Flisiak, Robert (Medical University of Bialystok) ; Grzeszczuk, Anna (Medical University of Bialystok) ; Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ; Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ; Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ; Beniowski, Marek (Medical University of Silesia in Katowice) ; Mularska, Elżbieta ; Jablonowska, Elżbieta (University of Lodz) ; Kamerys, J. (Poznan University of Medical Sciences) ; Wojcik, K. (University of Lodz) ; Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ; Rozplochowski, Błażej (Poznan University of Medical Sciences) ; Zagalo, A. (Hospital Santa Maria (Lisboa, Portugal)) ; Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ; Oprea, Cris (Joint Institute for Nuclear Research) ; Yakovlev, A. (Saint Petersburg State University) ; Trofimora, T. (Novgorod Centre for AIDS (Novgorod)) ; Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ; Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ; Borodulina, Elena (Samara State Medical University) ; Vdoushkina, Elena (Samara State Medical University) ; Ranin, Jovan (Klinički centar Srbije) ; Tomazic, J. (Ljubljana University Medical Centre) ; Miro, Josep M. (Instituto de Salud Carlos III) ; Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ; Martinez, E. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Garcia, F. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ; Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ; Mallolas Masferrer, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Callau, Pilar (Universitat de Barcelona) ; Rojas, J. (Hospital Clínic i Provincial de Barcelona) ; Moreno, Santiago (Pontifical Catholic University of Argentina) ; del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ; Jou, A. (IrsiCaixa Institute for AIDS Research) ; Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig, Jordi (Universitat Autònoma de Barcelona) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Gutierrez, M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sambeat, A. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Laporte, J.M. (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ; Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Sonnerborg, A. (Karolinska University Hospital) ; Flamholc, L. (Skåne University Hospital (Suècia)) ; Kusejko, Katharina (University of Zurich) ; Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ; Calmy, Alexandra (University of Geneva) ; Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ; Battegay, Manuel (University of Basel) ; Schmid, P. (Cantonal Hospital of Schwyz) ; Kuznetsova, A. (Kyiv National Economic University) ; Mikhalik, Julia (Crimean Republican AIDS centre) ; Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ; Milinkovic, Ana (Imperial College London) ; Johnson, A.M. (Mortimer Market Centre) ; Simons, Edwards (Mortimer Market Centre) ; Edwards, S. (Brookhaven National Laboratory) ; Phillips, A.M. (Royal Free and University College Medical School) ; Johnson, M.A. (Royal Free and University College Medical School) ; Mocroft, A. (Royal Free and University College Medical School) ; Orkin, Chloe (Queen Mary, University of London) ; Winston, Alan (Imperial College London) ; Clarke, A. (University of Sussex) ; Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 - 10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38  

See also: similar author names
1 Delforge, M
1 Delforge, Marc D.
1 Delforge, Michel
1 Delforge, Michele
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.